Aetna Inc. v. Gilead Sciences, Inc.

CourtDistrict Court, N.D. California
DecidedMarch 29, 2022
Docket3:21-cv-09827
StatusUnknown

This text of Aetna Inc. v. Gilead Sciences, Inc. (Aetna Inc. v. Gilead Sciences, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Aetna Inc. v. Gilead Sciences, Inc., (N.D. Cal. 2022).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 STALEY, et al., Case No. 19-cv-02573-EMC

8 Plaintiffs, ORDER DENYING DEFENDANTS’ 9 v. MOTION TO VACATE AETNA’S VOLUNTARY DISMISSAL 10 GILEAD SCIENCES, INC., et al., Docket No. 863 11 Defendants.

12 AETNA INC., RELATED TO

13 Plaintiff, Case No. 21-cv-09827-EMC 14 v.

15 GILEAD SCIENCES, INC., et al., Docket No. 19 16 Defendants.

17 18 The pending motion concerns Aetna v. Gilead, No. C-21-9827 EMC, which is one of the 19 cases related to the main Staley action. This case shall hereinafter be referred to as Aetna I. Aetna 20 filed Aetna I in state court, but Gilead removed the case to federal court. Aetna then moved to 21 remand. The same day that Gilead’s opposition to the remand motion was due, Aetna filed a 22 notice of voluntary dismissal pursuant to Federal Rule of Civil Procedure 41. Now pending before 23 the Court is Gilead’s motion to vacate the voluntary dismissal. 24 Having considered the parties’ briefs and accompanying submissions, as well as the oral 25 argument of counsel, the Court hereby DENIES Defendants’ motion. 26 /// 27 /// 1 I. FACTUAL & PROCEDURAL BACKGROUND 2 The evidence of record reflects as follows. 3 12/14/2021. Aetna filed suit in state court against Gilead, BMS, and Janssen. Aetna 4 asserted only state law claims. At or about the same time, Aetna’s counsel (the Crowell law firm) 5 also filed a number of cases on behalf of other individual health plans in federal court. 6 12/20/2021. Gilead removed Aetna I to federal court. Gilead claimed both diversity 7 jurisdiction and federal question jurisdiction as the basis for removal. 8 On diversity jurisdiction, Gilead acknowledged that it is a citizen of California (i.e., a 9 forum defendant) but asserted that removal was nevertheless proper because it had not yet been 10 served. See Docket No. 1 (Not. of Removal at 1-2); 28 U.S.C. § 1441(b)(2) (“A civil action 11 otherwise removable solely on the basis of the jurisdiction under section 1332(a) of this title [i.e., 12 diversity jurisdiction] may not be removed if any of the parties in interest properly joined and 13 served as defendants is a citizen of the State in which such action is brought.”) (emphasis added).1 14 On federal question jurisdiction, Gilead contended, inter alia, that substantial federal issues were 15 raised regarding federal patent law, the Hatch-Waxman Act, and the FDA regulatory scheme and 16 that the state law claims turned on federal antitrust law. 17 1/18/2022. Aetna filed a motion to remand. See Docket No. 12 (motion). The opposition 18 was set to be filed on 2/1/2022. 19 1/31/2022. Aetna filed a new complaint in state court. That case shall hereinafter be 20 referred to as Aetna II. The Aetna II complaint seems to be substantially the same as the Aetna I 21 complaint. 22 2/1/2022. Before Gilead could file its opposition to the motion to remand in Aetna I, 23 Aetna filed a notice of voluntary dismissal of Aetna I pursuant to Rule 41. See Docket No. 14 24 (notice); see also Fed. R. Civ. P. 41(a)(1)(A)(i) (“Subject to Rules 23(e), 23.1(c), 23.2, and 66 and 25

26 1 Gilead points out that this Court has previously stuck to the strict language of § 1441. See City of Ann Arbor Emples. Ret. Sys. v. Gecht, No. C-06-7453 EMC, 2007 U.S. Dist. LEXIS 21928, at 27 *22, 24-25 (N.D. Cal. Mar. 9, 2007) (approving defendant’s removal of case to federal court; 1 any applicable federal statute, the plaintiff may dismiss an action without a court order by filing: 2 (i) a notice of dismissal before the opposing party serves either an answer or a motion for 3 summary judgment.”). Thus, implicitly, Aetna was intending to proceed with Aetna II as its 4 litigation vehicle rather than Aetna I. That same day, Gilead filed a statement indicating that it 5 was looking into the propriety of the voluntary dismissal in Aetna I. See Docket No. 17 (response) 6 (taking note that Aetna had recently filed the Aetna II complaint). 7 2/3/2022. Gilead removed Aetna II from state to federal court. See Aetna v. Gilead, No. 8 C-22-0740 EMC (N.D. Cal.). 9 2/7/2022. In Aetna I, Defendants filed a motion to vacate the voluntary dismissal. This is 10 the currently pending motion. 11 2/16/2022. In Aetna II, Defendants filed a motion to dismiss, which is currently set for 12 hearing on 3/31/2022. The motion to dismiss is to be heard on the same day as other motions to 13 dismiss filed in Staley (all challenging complaints filed by individual health plans). 14 3/2/2022. In Aetna II, Aetna filed a motion to remand its case back to state court. The 15 motion is currently set for hearing on 4/7/2022. 16 II. DISCUSSION 17 Federal Rule of Civil Procedure 41 provides in relevant part as follows: “Subject to Rules 18 23(e), 23.1(c), 23.2, and 66 and any applicable federal statute, the plaintiff may dismiss an action 19 without a court order by filing: (i) a notice of dismissal before the opposing party serves either an 20 answer or a motion for summary judgment.” Fed. R. Civ. P. 41(a)(1)(A)(i). In the instant case, 21 there is no dispute that, at the time Aetna voluntarily dismissed Aetna I, no defendant had filed an 22 answer or a motion for summary judgment. Defendants argue, however, that Aetna was not free 23 to unilaterally voluntarily dismiss because Rule 41 says that a dismissal is subject to “any 24 applicable federal statute.” According to Defendants, there is an applicable federal statute that 25 prevents Aetna from unilaterally acting. Specifically, Defendants rely on the removal statutes 26 /// 27 /// 1 themselves (28 U.S.C. §§ 1446-472) and the All Writs Act (id. § 16513). Citing, inter alia, Lou v. 2 Belzberg, 834 F.2d 730 (9th Cir. 1987), Defendants argue that, because a court can – pursuant to 3 the removal statutes – issue an injunction to prevent a party from subverting the court’s removal 4 jurisdiction, this necessarily means that this Court can issue the “lesser remedy” of vacating 5 Aetna’s voluntary dismissal which is intended to subvert the Court’s removal jurisdiction. 6 The Court finds Defendants’ position unavailing. As a preliminary matter, it is notable 7 that Defendants have not cited any authority holding that the removal statutes or the All Writs Act 8 is an “applicable federal statute” for purposes of Rule 41. Nor was the Court able to find any such 9 authority based on its independent research. 10 In addition, the Court sees no principled reason to extend Rule 41 to include the removal 11 statutes or the All Writs Act as an “applicable federal statute.” In assessing what could be an 12 applicable federal statute, the Court takes guidance from Rule 41 which gives explicit examples 13 2 In its reply brief, Defendants relied on the following provisions specifically: 14

• Section 1446(d) which provides that “[p]romptly after the filing of such notice of removal 15 of a civil action the defendant or defendants shall give written notice thereof to all adverse parties and shall file a copy of the notice with the clerk of such State court, which shall 16 effect the removal and the State court shall proceed no further unless and until the case is remanded.” 28 U.S.C. § 1446

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Kenney
550 F. Supp. 2d 118 (D. Maine, 2008)
American Soccer Co. v. Score First Enterprises
187 F.3d 1108 (Ninth Circuit, 1999)
Lou v. Belzberg
834 F.2d 730 (Ninth Circuit, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
Aetna Inc. v. Gilead Sciences, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/aetna-inc-v-gilead-sciences-inc-cand-2022.